Houbo Deng

Dr. Houbo Deng


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2025 in Medicine
Verified
Journal Article
Open access
YQYI QU
YI QU
QGQing Gong
Qing Gong
HDHoubo Deng
Houbo Deng
WZWenhai Zhao
Wenhai Zhao
Although observational studies have suggested associations between cathepsins and inflammatory wrist diseases, critical controversies persist regarding the causality, directionality, and disease-specific mechanisms of these relationships. Conventional clinical studies are unable to determine whether cathepsin-disease associations reflect true causality or spurious links driven by confounding factors or reverse causation. Moreover, systematic causal analyses focusing on protease-mediated mechanisms in wrist-specific inflammatory pathologies remain notably absent. To address these gaps, this study employs bidirectional 2-sample Mendelian randomization (MR) to investigate the causal effects of cathepsins on inflammatory wrist diseases and elucidate their disease-specific roles, thereby providing genetic evidence for targeted therapeutic strategies. We performed bidirectional 2-sample MR using public genome-wide association study summary statistics to assess causal relationships between 10 cathepsins and 4 inflammatory wrist diseases. Instrumental variables (single nucleotide polymorphisms) were selected at genome-wide significance (P < 5 × 10⁻⁶, and r² < 0.001) for exposure-outcome associations. Causality was evaluated via inverse-variance weighted, MR-Egger, and Weighted Median methods. Sensitivity analyses included Cochran Q, MR-Pleiotropy Residual Sum and Outlier, MR-Egger and leave-one-out validation. Univariate MR analysis demonstrated a causal association between genetically determined levels of cathepsin S and the development of carpal tunnel syndrome (odds ratio [OR], 0.954 [95% CI, 0.925–0.984]; P = .003), wrist synovitis (OR, 0.708 [95% CI, 0.529–0.949]; P = .021), and rheumatoid arthritis (RA; OR, 1.048 [95% CI, 1.005–1.092]; P = .029). Similarly, a causal link was established between cathepsin L and RA (OR, 0.948 [95% CI, 0.906–0.991]; P = .019), and between cathepsin F and De Quervain tenosynovitis (OR, 1.213 [95% CI, 1.003–1.466]; P = .046). A reverse MR analysis suggested a causal relationship between cathepsin O and wrist synovitis (OR, 1.047 [95% CI, 1.003–1.093]; P = .038). No causal associations were found for other cathepsins with the diseases studied. The reliability of these findings was confirmed through various robustness tests. Genetic evidence confirms cathepsin S protects against carpal tunnel syndrome and wrist synovitis but increases RA risk. Cathepsin F is positively associated with De Quervain tenosynovitis. Conversely, wrist synovitis elevates cathepsin O levels through reverse causation. These findings validate pathogenic mechanisms of wrist inflammatory disorders and suggest targeted inhibition of specific cathepsins as a promising therapeutic strategy.

17 July 2026 in Medicine
Verified
Journal Article
Open access
PSPeng Sun
Peng Sun
CMChunlei Ma
Chunlei Ma
ZSZiqi Sang
Ziqi Sang
HDHoubo Deng
Houbo Deng
PDPeng Dai
Peng Dai
DZDongkai Zhao
Dongkai Zhao
Chronic obstructive pulmonary disease (COPD) is a leading cause of global mortality and has been linked to systemic inflammation and insulin resistance. The C-reactive protein–triglyceride–glucose index (CTI), a composite biomarker integrating inflammatory and metabolic components, may reflect these intertwined pathways. However, its association with COPD in the general population remains unclear. In this cross-sectional study, we analyzed data from 3442 adults aged ≥20 years participating in the National Health and Nutrition Examination Survey 2015 to 2018. Weighted multivariable logistic regression models were used to assess the association between CTI and self-reported COPD. Dose–response relationships were evaluated using restricted cubic splines. Subgroup and interaction analyses were performed across demographic and socioeconomic factors. Receiver operating characteristic (ROC) curves were constructed to compare the discriminatory ability of CTI with individual biomarkers. Mean CTI levels were higher among participants with COPD compared to those without COPD (9.29 vs 8.95; P < .001). After adjustment for potential confounders, participants in the highest CTI quartile had a modestly increased likelihood of COPD compared with those in the lowest quartile (odds ratio = 1.04, 95% confidence interval: 1.02–1.07). A linear dose–response association was observed ( P for nonlinearity = .319). A statistically significant interaction by sex was identified, with a stronger association observed in males. In ROC curve analysis, CTI demonstrated slightly higher discriminatory ability (area under the ROC curve = 0.630) than individual biomarkers, although overall predictive performance remained limited. In this nationally representative cross-sectional analysis, higher CTI levels were independently associated with COPD prevalence, with a modest effect size. While CTI showed slightly improved discriminatory performance compared with single biomarkers, its overall predictive capacity was limited. Prospective studies are warranted to clarify its potential role in COPD risk assessment.